ITCI: Intra-Cellular Therapies Company Short-Term Debt
The price evolution of Intra-Cellular Therapies (ITCI) on the GURU.Markets platform, where the indicator stands at 0.00, demonstrates the stability of a business shielded from external conflicts by operating within the US. Intra-Cellular Therapies develops cutting-edge treatments for depression and schizophrenia, distinguishing itself through the absence of weight-gain side effects. Growth is driven by the integration of Caplyta into the hospital sector and the pursuit of new therapeutic targets.
Intra-Cellular Therapies Inc. (ITCI) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Equity Ratio Intra-Cellular Therapies|ITCI - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Intra-Cellular|ITCI - Aggregate Debt Obligations|Debts to Book Capitalization Intra-Cellular Therapies, Inc.|ITCI - Company Long-Term Debts|Company Current Liabilities Intra-Cellular Therapies|Quick Ratio intracellulartherapies.com
- net income and valuation multiples indicators:
General company analysis:intracellulartherapies.com (ITCI)
Fundamental analysis of Intra-Cellular Therapies (ITCI) requires a liquidity assessment to ensure the stable development of its innovative potential. The dynamics of short-term accounts payable and loans reflect obligations due within a year, which is critical when scaling robotic cell monitoring systems, allowing investors to evaluate the risk of cash flow gaps during accelerated drug development without excessive headcount expansion.
Competitors of Intra-Cellular Therapies (ITCI)
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|xenon-pharma.com (XENE) - Short-Term Debt Volume|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Supernus Pharmaceuticals, Inc. - Company Short-Term Indebtedness|Catalyst Pharmaceuticals Inc - Company Current Liabilities|Amount of Current Liabilities DNLI (Denali Corp)|HRMY - Company Short-Term Debt|Company Short-Term Loans and Borrowings BHVN (biohavenpharma.com)|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|Company Current Liabilities PRAX|AVXL - Short-Term Indebtedness|Company Short-Term Debts CBLL|Company Current Liabilities Prothena Corporation plc PRTA|Company Short-Term Debts ALEC (Alector)|Annexon Biosciences (ANNX) - Short-Term Debt|OMER - Company Short-Term Debt|NGNE: Company Short-Term Debt|AC Immune (ACIU) - Company Short-Term Debt|VYGR (voyagertherapeutics.com) - Company Short-Term Debt|Company Current Liabilities NMRA|Company Short-Term Debts Scilex Holding|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|Company Short-Term Debt ACOG (alphacognition.com)|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Debts inhibikase.com IKT|SAVA - Company Short-Term Debt|Company Short-Term Loans and Borrowings ASRT (Assertio Holdings, Inc.)|COYA (coyatherapeutics.com) - Company Current Liabilities|Vistagen - Company Short-Term Loans and Borrowings|Company Current Liabilities OVID|ABOS (acumenpharm.com) - Amount of Current Liabilities|Company Short-Term Debts CRVO|ATHE (alteritytherapeutics.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLNN (Clene)|PepGen Inc (PEPG) - Short-Term Debt|JUNS - Company Short-Term Debt|Company Short-Term Loans and Borrowings RLMD (relmada.com)|ANVS: Company Short-Term Debts|Grace Therapeutics (GRCE) - Company Short-Term Debts|Company Short-Term Debt Firefly Neuroscience Inc|ANEW Medical, Inc. - Current Liabilities|Company Short-Term Debts NRSN|Short-Term Debt Volume revivapharma.com|Company Short-Term Debts MTVA (MetaVia)|NeurAxis Inc. (NRXS) - Short-Term Debt|HSDT - Company Short-Term Debt|Short-Term Debt Volume Passage Bio, Inc. PASG|NEUP: Company Short-Term Debts|NERV - Short-Term Debt Volume|Company Current Liabilities ATHA|ADXN (Addex Therapeutics Ltd.) - Amount of Current Liabilities|Company Short-Term Debts ALZN|Company Current Liabilities cyclerion.com CYCN|Company Short-Term Debts PTIX (Protagenic Therapeutics, Inc.)|Short-Term Debt Volume Pasithea Therapeutics Corp (KTTA)|CRGT - Company Short-Term Debt|ATXI (Avenue Therapeutics Inc.) - Company Short-Term Indebtedness|BCLI: Company Short-Term Debts|Short-Term Debt Cara Therapeutics Inc (CARA)|Company Current Liabilities CHRO|Company Short-Term Debts Eliem|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|MRNS (Marinus Pharmaceuticals Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NKGen NKGN|NeuroBo Pharma (NRBO) - Short-Term Debt|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume synaptogen.com SNPX|Trevena (TRVN) - Company Short-Term Debt|Company Short-Term Indebtedness VIGL|Company Current Liabilities WENA|CERE (Cerevel Corp) - Amount of Current Liabilities